{{Rsnum
|rsid=7561273
|Gene=MFSD2B
|Chromosome=2
|position=24024644
|Orientation=plus
|GMAF=0.3884
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MFSD2B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 25.0 | 50.0 | 25.0
| HCB | 2.9 | 29.9 | 67.2
| JPT | 0.0 | 23.2 | 76.8
| YRI | 24.5 | 50.3 | 25.2
| ASW | 22.8 | 52.6 | 24.6
| CHB | 2.9 | 29.9 | 67.2
| CHD | 2.8 | 26.6 | 70.6
| GIH | 36.6 | 45.5 | 17.8
| LWK | 33.6 | 59.1 | 7.3
| MEX | 12.1 | 31.0 | 56.9
| MKK | 30.8 | 48.7 | 20.5
| TSI | 20.6 | 49.0 | 30.4
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19197348
|Trait=Quantitative traits
|Title=Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae
|RiskAllele=A
|Pval=0.000006
|OR=0.22
|ORtxt=[NR] mg/L decrease
|OA=1
}}

C-reactive protein ([[CRP]]) levels being the quantitative trait associated with in {{PMID|19197348|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7561273
|overall_frequency_n=77
|overall_frequency_d=128
|overall_frequency=0.601562
|n_genomes=42
|n_genomes_annotated=0
|n_haplomes=63
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}